Alembic Pharmaceuticals Limited (Aplltd) (NSE: APLLTD) and Zota Health Care Ltd (NSE: ZOTA) are both listed in the Non-Prescription Drugs industry. Alembic Pharmaceuticals has a market capitalisation of ₹15,784 Cr and Zota Health Care ₹4,215 Cr, as of 9 Nov 2026. Return on equity is 12.36% for Alembic Pharmaceuticals and -16.05% for Zota Health Care. Over one year, Alembic Pharmaceuticals's share price is up 10.3% and Zota Health Care's is down 15.9%.
| Metric | Alembic Pharmaceuticals | Zota Health Care |
|---|---|---|
| NSE Symbol | APLLTD | ZOTA |
| BSE Code | 533573 | — |
| Share Price | ₹1,019.00 | ₹1,273.60 |
| Market Cap | ₹15,784 Cr | ₹4,215 Cr |
| P/E Ratio | 23.4 | Not meaningful (loss) |
| Return on Equity | 12.36% | -16.05% |
| Return on Assets | 6.03% | -5.07% |
| Dividend Yield | 1.49% | 0.08% |
| Beta (1Y) | 0.29 | 0.23 |
| 1-Year Price Change | +10.3% | -15.9% |
| 3-Month Price Change | +22.6% | -0.1% |
| 52-Week Range | ₹635.80 – ₹1,055.70 | ₹1,022.00 – ₹1,740.00 |
| Latest Quarter | Q2 FY27 | Q2 FY27 |
| Quarterly Revenue | ₹2,603 Cr | ₹199 Cr |
| Quarterly Net Profit | ₹334 Cr | ₹-26 Cr |
| Net Margin | 12.8% | -13.0% |
| EPS (Basic, Quarter) | ₹17.05 | ₹-7.39 |
| Results Basis | consolidated | consolidated |
| Headquarters | Vadodara, Gujarat | Surat, Gujarat |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It a…
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.
Alembic Pharmaceuticals has a market capitalisation of ₹15,784 Cr, against ₹4,215 Cr for Zota Health Care as of 9 Nov 2026, about 3.7 times the size by market cap.
Alembic Pharmaceuticals has a return on equity of 12.36% and Zota Health Care -16.05%.
Alembic Pharmaceuticals's share price is up 10.3% over one year and Zota Health Care's is down 15.9%.
Alembic Pharmaceuticals reported revenue of ₹2,603 Cr and net profit of ₹334 Cr for Q2 FY27. Zota Health Care reported revenue of ₹199 Cr and net profit of ₹-26 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Pharmaceuticals > Non-Prescription Drugs on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.